✦ LIBER ✦

ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

✍ Scribed by Buller, C. E.; Fu, Y.; Mahaffey, K. W.; Todaro, T. G.; Adams, P.; Westerhout, C. M.; White, H. D.; van 't Hof, A. W.J.; Van de Werf, F. J.; Wagner, G. S.; Granger, C. B.; Armstrong, P. W.

Book ID: 118196522
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 559 KB
Volume: 118
Category: Article
ISSN: 0009-7322
DOI: 10.1161/circulationaha.108.767772

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting chronic left ventricular dysf

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy

✍ Justin A. Ezekowitz; Paul W. Armstrong; Christopher B. Granger; Pierre Theroux; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Pexelizumab fails to inhibit assembly of

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Catherine Martel; Christopher B. Granger; Marta Ghitescu; Amanda Stebbins; Annik 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Does silent myocardial infarction add pr

Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

✍ Mustafa Toma; Yuling Fu; Justin A. Ezekowitz; Finlay A. McAlister; Cynthia M. We 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Comparative Early and Late Outcomes Afte

Comparative Early and Late Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment Elevation and Non–ST-Segment Elevation Acute Myocardial Infarction (from the CADILLAC Trial)

✍ David A. Cox; Gregg W. Stone; Cindy L. Grines; Thomas Stuckey; Peter J. Zimetbau 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Cardiogenic shock and heart failure post

Cardiogenic shock and heart failure post–percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from “Assessment of Pexelizumab in Acute Myocardial Infarction”

✍ John K. French; Paul W. Armstrong; Eric Cohen; Neal S. Kleiman; Christopher M. O 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Outcome of elderly patients undergoing p

Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction

✍ Peter Wenaweser; Marianne Ramser; Stephan Windecker; Indira Lütolf; Bernhard Mei 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views